Revised genomic organization of FBN1 and significance for regulated gene expression

Genomics

Volumn 56, Issue 1, 1999, Pages 70-77

  Biery, Nancy Jensen ^a   Eldadah, Zayd A ^a   Moore, Clara S ^a   Stetten, Gail ^a   Spencer, Forrest ^a   Dietz, Harry C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; FIBRILLIN; METHIONINE; PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE EXPRESSION; HUMAN; MARFAN SYNDROME; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION MAPPING; SOUTHERN BLOTTING; SWINE; YEAST ARTIFICIAL CHROMOSOME;

EID: 0033558206     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5697     Document Type: Article

References (29)

1. Brinster R. L., Allen J. M., Behringer R. R., Gelinas R. E., Palmiter R. D. Introns increase transcriptional efficiency in transgenic mice. Proc. Natl. Acad. Sci. USA. 85:1988;836-840.
2. Choi T., Huang C., Gorman C., Jaenisch R. A generic intron increases gene expression in transgenic mice. Mol. Cell. Biol. 11:1991;3070-3074.
3. Church G. M., Gilbert W. Genomic sequencing. Proc. Natl. Acad. Sci. USA. 81:1984;1991-1995.
4. Corson G. M., Chalberg S. C., Dietz H. C., Charbonneau N. L., Sakai L. Y. Fibrillin binds calcium and is encoded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5′ end. Genomics. 17:1993;476-484.
5. Dietz H. C., Cutting G. R., Pyeritz R. E., Maslen C. L., Sakai L. Y., Corson G. M., Puggenberger E. G., Hamosh A., Nanthakumar E., Curristin S., Stetten G., Meyers D. A., Francomano C. A. Marfan syndrome caused by a recurrentde novo. Nature. 352:1991;337-339.
6. Dietz H. C., Pyeritz R. E., Puffenberger E. G., Kendzior R. J., Corson G. M., Maslen C. L., Sakai L. Y., Francomano C. A. Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. J. Clin. Invest. 89:1992;1674-1680.
7. Dietz H., Ramirez F., Sakai L. Marfan syndrome and other microfibrillar diseases. Advances in Human Genetics. 1994;Plenum, New York. p. 153-186.
8. Dietz H. C., Pyeritz R. E. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum. Mol. Genet. 4:1995;1799-1809.
9. Eldadah Z. A., Brenn T., Furthmayr H., Dietz H. C. Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a marfan cellular phenotype. J. Clin. Invest. 95:1995;874-880.
10. Jorcyk C. L., Garrett L. J., Maroulakou I. G., Watson D. K., Green J. E. Multiple regulatory regions control the expression ofEts-1. Cell. Mol. Biol. 43:1997;211-225.
11. Kozak M. An analysis of vertebrate mRNA sequences: Intimations of translational control. J. Cell Biol. 115:1991;887-903.
12. Lamb B. T., Gearhart J. D. YAC transgenics and the study of genetics and human disease. Curr. Biol. 5:1995;342-348.
13. McEwen D. G., Ornitz D. M. Regulation of the fibroblast growth factor receptor 3 promoter and intron I enhancer bySp1. J. Biol. Chem. 273:1998;5349-5357.
14. McKusick V. A. Mendelian Inheritance in Man. 1993;Johns Hopkins Univ. Press, Baltimore.
15. Mecham R. P., Heuser J. E. The elastic fiber. Hay E. D. Cell Biology of the Extracellular Matrix. 1991;79-109 Plenum, New York.
16. Muragaki Y., Nishimura I., Henney A., Ninomiya Y., Olsen B. R. The α1 (IX) collagen gene gives rise to two different transcripts in both mouse embryonic and human fetal RNA. Proc. Natl. Acad. Sci. USA. 87:1990;2400-2404.
17. Nijbroek G., Sood S., McIntosh I., Francomano C. A., Bull E., Pereira L., Ramirez F., Pyeritz R. E., Dietz H. C. Fifteen novelFBN1. Am. J. Hum Genet. 57:1995;8-21.
18. Nishimura I., Muragaki Y., Olsen B. R. Tissue-specific forms of type IX collagen-proteoglycan arise from the use of two widely separated promoters. J. Biol. Chem. 264:1989;20033-20041.
19. Pavan W. J., Hieter P., Sears D., Burkhoff A., Reeves R. H. High efficiency yeast artificial chromosome fragmentation vectors. Gene. 106:1991;125-127.
20. Pearson W. R. Rapid and sensitive sequence comparison with FASTP and FASTA. Methods Enzymol. 183:1990;63-98.
21. Pearson W. R. Comparison of methods for searching protein sequence databases. Protein Sci. 4:1995;1145-1160.
22. Pereira L., D'Alessio M., Ramirez F., Lynch J. R., Sykes B., Pangilinan T., Bonadio J. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum. Mol. Genet. 2:1993;961-968.
23. Pereira L., Andrikopoulos K., Tian J., Lee S. Y., Keene D. R., Ono R., Reinhardt D. P., Sakai L. Y., Biery N. J., Bunton T., Dietz H. C., Ramirez F. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat. Genet. 17:1997;218-222.
24. Pinkel D., Straume T., Gray J. W. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc. Natl. Acad. Sci. USA. 83:1986;2934-2938.
25. Sakai L. Y., Keene D. R., Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J. Cell Biol. 103:1986;2499-2509.
26. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Plainview. p. 1.42-1.45.
27. Spencer F., Ketner G., Connelly C., Hieter P. Targeted recombination-based cloning and manipulation of large DNA segments in yeast. Methods Companion Methods Enzymol. 5:1993;161-175.
28. Tilstra D. J., Li L., Potter K. A., Womack J., Byers P. H. Sequence of the coding region of the bovine fibrillin cDNA and localization to bovine chromosome 10. Genomics. 23:1994;480-485.
29. Yin W., Smiley E., Germiller J., Sanguineti C., Lawton T., Pereira L., Ramirez F., Bonadio J. Primary structure and developmental expression of Fbn-1, the mouse fibrillin gene. J. Biol. Chem. 270:1995;1798-1806.